CX 2024 Preliminary Programme

Showing the latest CX 2024 Programme, talks, speakers and timings subject to change.
The organisers reserve the right to alter the programme as necessary.
All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter the timings if necessary.

Day 3 Morning: Aortic Arch & Dissection Controversies - Thursday, 25th April
Venue:   Theatre 1
Aortic Arch Controversies
Sex-related outcomes of endovascular aortic arch repair: A single centre study
Speaker:   Petroula Nana, Hamburg, Germany
Audience participation & discussion
Edited Case: Aortic arch repair using a new hybrid device design
Speaker:   Aung Ye Oo, London, United Kingdom
Audience participation & discussion
Carbon-dioxide flushing reduces cerebral damage in TEVAR and TAVR
Speaker:   Lydia Hanna, London, United Kingdom
Audience participation & discussion
Podium First: Outcomes of fenestrated vs. branched TEVAR for aortic arch pathologies
Speaker:   Fiona Rohlffs, Regensburg, Germany
Audience participation & discussion
Simplifying aortic arch disease treatment to achieve better outcomes: The EVERGREEN study
Speaker:   Ludovic Canaud, Montpellier, France
Audience participation & discussion
A new minimally invasive continuous suturing device for large-bore closure
Speaker:   Alexander Zimmermann, Zurich, Switzerland
Audience participation & discussion
 
Sponsored education
Aortic Dissection Controversies
Options for endovascular repair of ascending aortic pathologies
Speaker:   Joseph Bavaria, Pennsylvania, United States
Audience participation & discussion
Hospital incidence, mortality and sex disparities in patients treated for type A aortic dissections in Switzerland
Speaker:   Alexander Zimmermann, Zurich, Switzerland
Audience participation & discussion
Optimal timing of TEVAR for uncomplicated type B aortic dissection: A systematic review and meta-analysis
Speaker:   Vikram Puttaswamy, St Leonards, Australia
Audience participation & discussion
Great Debate: Best Medical Treatment remains the standard for uncomplicated acute type B aortic dissection

For the motion
Kevin Mani, Uppsala, Sweden
Hence Verhagen, Rotterdam, Netherlands

Against the motion
Christoph Nienaber, London, United Kingdom
Firas F Mussa, New York, United States

Audience participation & discussion
Podium First: Outcomes of acute aortic dissection in the UK
Speaker:   Arun Pherwani, Stoke-on-Trent, United Kingdom
Audience participation & discussion
Podium First: Does sex or ethnicity matter in type B aortic dissections: An experience of over 500 subjects
Speaker:   Frank Arko, Charlotte, United States
Audience participation & discussion
Predicting outcomes from type B intramural haematoma: Outcomes from a multi-centre study
Speaker:   Ian Loftus, London, United Kingdom
Audience participation & discussion
International experience with a false lumen endograft in aortic dissection
Speaker:   Tilo Koelbel, Hamburg, Germany
Audience participation & discussion
Off-the-shelf single branched TEVAR for the treatment of acute TBADs: An anatomical feasibility study
Speaker:   Benedikt Reutersberg, Zurich, Switzerland
Audience participation & discussion
Six years’ experience with a novel dissection-specific stent-graft to prevent distal stent-graft-induced new entry (dSINE)
Speaker:   Kevin Mani, Uppsala, Sweden
Audience participation & discussion
Five-year type B dissection outcomes
Speaker:   Santi Trimarchi, Milano, Italy
Audience participation & discussion
 
Sponsored education